AP govt issues notice to Aurobindo Pharma over fire accident
PTI | 06:12 PM,Dec 21,2011Hyderabad, Dec 21 (PTI) Andhra Pradesh government has issued a notice to the city-based drug maker Aurobindo Pharma in connection with a fire accident last month that claimed lives of two workers at its manufacturing plant located in Srikakulam district, a senior official said today. According to a senior official of the Directorate of Factories, the notice was issued to the company seeking explanation about the incident and also questioning some of the safety aspects which might have led to the same. D Chandrasekhar Varma, Joint Chief Inspector of Factories, said the incident occurred during a process involving a chemical called Trityl Perchlorate and samples of the chemical were sent for examination. "We have issued the notice to Aurobindo Pharma asking them as to what led to the accident. Based on their reply, there could be some investigation further. The whole process will be completed in three months," Varma told PTI. The department ordered the drug maker to suspend operations at the plant where the mishap took place. When contacted, a company spokesperson said the state government might have issued the notice as part of the "routine" process. Two persons were killed and one injured in a fire accident when a blast occurred at the generic drug maker's Active Pharma Ingredients (API) manufacturing plant at Pydibhimavaram in Srikakulam district near Visakhapatnam on November 28. "The powder processing area is isolated from the intermediate block. There was no impact to the operations as well as to the assets," Aurobindo Pharma had said in a statement after the incident. PTI GDK NSK
displayed with permission. Use of the CNN name and/or logo on or as part of CNN-IBN does not derogate from the intellectual property rights of Cable News Network in respect of them.
Disclaimer: Network18 Media & Investments Limited is proposing, subject to market conditions and other considerations, an offer of its equity shares on rights basis and has filed a Draft Letter of Offer with the Securities and Exchange Board of India. The Draft Letter of Offer is available on the website of SEBI at